Drug and pharmaceutical recalls
354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 6 of 12- Ascend dabigatran capsules recalled for failed impurity tests
Ascend Laboratories is recalling dabigatran etexilate capsules, 110 mg, after an out-of-specification result in 12-month long-term stability testing for Impurity II, Impurity III and total impurities. This means the product failed its impurity specifications. No injuries have been reported.
FDAJul 29, 2026Ascend Laboratories2 products
- JB Chemicals cetirizine tablets recalled for ranitidine cross-contamination
Customers reported discolored cetirizine tablets with red dots. The agency determined the red dots to be ranitidine, which is a cross-contamination from other products. The recall covers Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottles, made by Unique Pharmaceuticals Labs and distributed by Rising Pharma Holdings.
SeriousFDAJul 29, 2026JB Chemicals
- Fresenius Kabi Xylocaine, Naropin and more recalled over hair
Fresenius Kabi is recalling five injectable medicine products because hair was found in some vials. The products are Xylocaine (two sizes), Naropin, lidocaine HCl injection and glycopyrrolate injection, all made by Fresenius Kabi in Lake Zurich, Illinois, and sold nationwide. No injuries have been reported.
ModerateFDAJul 29, 2026Fresenius Kabi5 products
- Rising cyproheptadine syrup recalled for precipitate in bottle
Rising Pharma's Cyproheptadine Hydrochloride Syrup (2 mg/5 mL, 473 mL bottles) is being recalled because the medication is crystallizing and forming particles that float in the bottle. This affects specific batches distributed nationwide. No injuries have been reported.
ModerateFDAJul 29, 2026Rising Pharma
- Rohto Cooling Eye Drops recalled for sterility concerns
Rohto-Mentholatum is recalling eight Rohto Cooling Eye Drops products because they lack assurance of sterility, meaning the drops may not be guaranteed free of microbial contamination. All eight are sold under the Rohto Cooling Eye Drops name: ALL-IN-ONE, Max Strength (three versions), Optic Glow, Digi Eye, Dry Aid (single and twin pack), and Cool Relief. No injuries have been reported.
ModerateFDAJul 29, 2026Rohto-Mentholatum8 products
- Asclemed Lidolog Kit recalled for barcode label issue
Asclemed USA Inc. is recalling Lidolog Kit, which contains lidocaine injection, because the label wrap covers the barcode, making it difficult to scan. This labeling defect affects 18 kits distributed in Tennessee.
FDAJul 29, 2026Asclemed
- Ascend amlodipine and olmesartan tablets recalled for failed dissolution
Ascend Laboratories is recalling one lot of amlodipine and olmesartan medoxomil combination tablets (10 mg/20 mg) because the olmesartan medoxomil active ingredient is below the required amount. This means affected tablets may not work as intended to lower blood pressure.
ModerateFDAJul 29, 2026Ascend Laboratories
- Major Pharmaceuticals levothyroxine 25 mcg recalled for subpotency
Major Pharmaceuticals is recalling one lot of Levothyroxine Sodium Tablets, USP, 25 mcg due to subpotency — meaning the tablets contain less active ingredient than labeled. This affects Lot N02212 with an expiration date of 07/2026. Patients taking subpotent levothyroxine may not receive the full intended dose of this thyroid hormone replacement medication.
ModerateFDAJul 29, 2026Major Pharmaceuticals12 products
- Precision Dose glycopyrrolate solution recalled for impurity
Precision Dose Inc. is recalling one lot of Glycopyrrolate Oral Solution (1 mg/5 mL) due to an unidentified impurity found during routine stability testing that does not meet specification. The affected lot (506033) expires November 30, 2026. This medication is prescription-only and supplied in unit-dose oral syringes.
ModerateFDAJul 29, 2026Precision Dose2 products
Sunny Pharmtech Cyclophosphamide recalled for steel particlesSunny Pharmtech is recalling three lots of Cyclophosphamide for Injection (1g and 2g vials) distributed between May 2024 and October 2024 because steel particles were found in the product. No injuries have been reported so far, but steel particles in an intravenous injection could cause serious complications including blood clots and infection.
SeriousFDAJul 24, 2026Sunny Pharmtech
Baxter Cefazolin Dextrose Injection recalled for particulate contaminationBaxter is recalling one lot of Cefazolin in Dextrose Injection (a frozen antibiotic infusion bag) because cardboard particles were found in the solution. The affected lot (LD175708, expiring February 14, 2027) was distributed between March and June 2025. No injuries have been reported so far.
SeriousFDAJul 24, 2026Baxter
American Regent Papaverine Injection recalled for glass particlesAmerican Regent identified glass and paraformaldehyde particles in one lot of Papaverine Hydrochloride Injection (Lot #25202), a prescription medication used to improve blood circulation and treat muscle spasms. The particles could cause local irritation, blood vessel blockage, and serious complications including stroke.
SeriousFDAJul 24, 2026American Regent
- BD ChloraPrep Clear recalled for packaging seal defect
BD ChloraPrep Clear, a sterile skin antiseptic solution used before medical procedures, may have open or incomplete seals on individual applicator packaging. This could allow contamination of the sterile product. The issue affects multiple lot numbers distributed nationwide.
ModerateFDAJul 22, 2026CareFusion
- Chiesi CLEVIPREX injection recalled for sterility concerns
Chiesi USA is recalling specific lots of CLEVIPREX (clevidipine) injectable emulsion because the manufacturer cannot guarantee the vials are sterile. This affects vials distributed nationwide with lot numbers 1239521 and 1237454, expiring in October 2027. No injuries have been reported.
ModerateFDAJul 22, 2026Chiesi
- Carbamide peroxide ear drops recalled for low potency
Bell Pharmaceuticals is recalling 11 carbamide peroxide 6.5% ear drop products, all 0.5 fl oz (15 mL), sold under store and pharmacy brands. Testing found the drops contain far less active ingredient than the label states, and their acidity is also off. No injuries have been reported.
ModerateFDAJul 22, 2026Bell Pharmaceuticals11 products
- Padagis Nystatin Cream recalled for reduced potency
Padagis Nystatin Cream USP (100,000 units, 15 g tube, lot #205060, expiring 09/30/2027) has been recalled because stability testing found the active ingredient fell below the required strength specification. The cream may not work as effectively as intended to treat fungal infections.
ModerateFDAJul 22, 2026Padagis
Unique Pharmaceutical cetirizine 5 mg recalled for potential ranitidine cross-contaminationFour lots of Unique Pharmaceutical Cetirizine Hydrochloride 5 mg tablets were found to be cross-contaminated with ranitidine. The contamination was discovered when pharmacy staff noticed red discoloration on some tablets. People with sensitivity to ranitidine could experience serious allergic reactions.
SeriousFDAJul 18, 2026Unique Pharmaceutical Laboratories
- Cipla Cinacalcet tablets recalled for impurity risk
Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain elevated levels of N-nitroso-cinacalcet, a manufacturing impurity that exceeds FDA safety limits. The affected bottles were distributed nationwide.
ModerateFDAJul 8, 2026Cipla3 products
- Lannett amphetamine extended-release capsules recalled for label mix-up
Lannett Company distributed amphetamine extended-release capsules that contained only immediate-release pellets but were labeled as extended-release. This labeling error could result in incorrect dosing and medication timing for patients who depend on the extended-release formulation.
ModerateFDAJul 8, 2026Lannett
- Accucaine and lidocaine injection recalled for sterility concerns
Asclemed USA Inc. is recalling two lidocaine HCl 1% injection products in 5 mL single-dose ampules, sold nationwide. One is sold as Accucaine kits and the other is an unbranded lidocaine injection; both were distributed by Enovachem Pharmaceuticals. The recall was issued because the products may not be sterile, and no injuries have been reported.
ModerateFDAJul 8, 2026Asclemed USA Inc.2 products
- Synjardy XR tablets recalled for manufacturing deviations
Boehringer Ingelheim Pharmaceuticals is recalling one lot of Synjardy XR 12.5/1000 mg tablets due to manufacturing quality control issues. During production, an incorrect cleaning agent was used on equipment, and required testing of that equipment was not completed before the tablets were made.
ModerateFDAJul 8, 2026Boehringer Ingelheim
- Accord levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.
ModerateFDAJul 8, 2026Accord Healthcare
- Lupin prednisolone acetate eye drops recalled for foreign substance
Lupin Pharmaceuticals is recalling multiple lots of prednisolone acetate ophthalmic suspension 1% (an anti-inflammatory eye drop) due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.
ModerateFDAJul 8, 2026Lupin
- Accord BioPharma IMULDOSA injection recalled for sterility concerns
Accord BioPharma is recalling one lot of IMULDOSA (ustekinumab-srlf) injection due to lack of assurance that the product is sterile. The affected lot may not meet sterility standards required for injectable medications. No injuries have been reported.
ModerateFDAJul 8, 2026ACCORD BIOPHARMA INC
- BD ChloraPrep and PurPrep applicators recalled for sterility concerns
CareFusion is recalling 10 antiseptic skin prep products sold as BD ChloraPrep (Hi-Lite Orange, Clear and Scrub Teal), BD PurPrep, and ChloraPrep FREPP. Applicators that were meant to be sterilized before use were instead shipped to customers outside the intended distribution channel, so they may not be sterile. No injuries have been reported.
ModerateFDAJul 8, 2026CareFusion10 products
- Lupin Glucagon Emergency Kit recalled for plunger defect
Lupin Pharmaceuticals is recalling certain lots of its Glucagon Emergency Kit because the syringe plunger may not move smoothly during use. This defect was discovered during stability testing and could prevent the kit from working properly in an emergency.
ModerateFDAJul 8, 2026Lupin
- Sun Pharmaceutical perampanel 6 mg tablets recalled for label mix-up
Sun Pharmaceutical discovered that some bottles labeled as containing 6mg Perampanel tablets actually contained 10mg tablets instead. This mix-up affects one lot (AE01763) distributed nationwide. Patients taking the wrong strength could receive an incorrect dose of this seizure medication.
ModerateFDAJul 1, 2026Sun Pharmaceutical
- Elevate Oral Care Povi-One antiseptic recalled for subpotency
Elevate Oral Care's Povi-One 10% Povidone-Iodine Oral Antiseptic does not contain the full strength stated on the label. Five specific production lots distributed nationwide do not meet the required potency standard, which means the product may not work as intended for oral antiseptic purposes.
ModerateFDAJul 1, 2026Elevate Oral Care
- Annora lacosamide tablets recalled for possible selexipag mix-up
Some bottles of Lacosamide 100mg tablets may contain Selexipag 1000 mcg tablets instead. This mix-up happened during manufacturing and could cause patients to take the wrong medication. The recall affects specific lots distributed nationwide.
ModerateFDAJul 1, 2026Annora Pharma
- BD ChloraPrep applicators recalled for sterility risk
CareFusion is recalling four sizes of BD ChloraPrep Clear and BD ChloraPrep FREPP Clear skin antiseptic applicators because wrinkles in the paper lid may break the seal, so the products may not stay sterile. No injuries have been reported. The products were distributed nationwide in the U.S. and to other countries.
ModerateFDAJul 1, 2026CareFusion4 products